Furthermore, severe hypoglycemic event rates with Gla-300 (estimated though a predictive modeling approach) were not different from those with Deg-100, whereas predicted rates of non-severe hypoglycemia were significantly lower with Gla-300 versus all comparators (first- and second-generation basal insulins). Here, INS is linked to Hypoglycemia.